Recent results from Taylor Wimpey and Vistry and updates from Persimmon, Berkeley provide mixed picture of stabilising demand but continued margin pressures.
The UK housebuilding sector is back in the spotlight as a wave of company updates provides fresh insight into the health of the housing market. Results from Taylor Wimpey, alongside recent news around Vistry, and upcoming updates from Persimmon and Berkeley Group, are offering investors a mixed picture of stabilising demand but continued pressure on profitability.
Attention is now turning to Persimmon’s full-year results, due on 11 March, which are expected to provide one of the clearest indicators of how the sector navigated 2025’s housing market conditions.
The builder previously reported improving performance in its FY 2024 figures, including a 7 percent increase in completions to 10,664 homes and stronger private sales volumes, reflecting a gradual recovery in buyer activity following a period of elevated mortgage rates and weaker demand.
Revenue also rose year-on-year (YoY) to roughly £3.2 billion, while profit margins remained under pressure due to higher costs and incentives used to support sales.
For full-year 2025 results a 10% rise in revenue to £3.53 billion is expected to be announced as well as a similar increase in pre-tax profit to £437.8 million and earnings per share (EPS) rise of 6.8% to 97.3 pence.
Investors will also be watching closely for commentary on forward sales, reservation rates and pricing trends to determine whether improving demand seen late in 2024 has continued into 2025.
According to LSEG Data & Analytics, analysts rate Persimmon as a ‘buy’ with a mean long-term price target at 1623.35p, around 25% above the current share price, as of 6 March 2026.
Persimmon has a TipRanks Smart Score of ‘6 Neutral’ but is rated as a ‘buy.’
Persimmon’s share price saw a near 50% advance from its September low to it February high but this week fell out of its clearly defined uptrend channel, dragged down by the 25% Vistry share price drop and the war in the Middle East. Rising oil prices push back Bank of England (BoE) rate cut expectations amid inflation fears and are thus weighing on housing affordability and by extension on UK housebuilder share prices.
The 15% slide in Persimmon’s share price from its mid-February near 1 ½ year 1552p high means that all this year’s gains have been wiped off.
The October to mid-November 2025 highs and December low at 1292.5p - 1,278.5p represent a key support area which the persimmon share price is getting very close to. While it holds on a weekly chart closing basis, the medium-term uptrend is deemed to stay intact despite this week’s sharp sell-off.
Were this support zone to give way, though, the 200-day simple moving average (SMA) at 1,268.3p may be revisited, and, if fallen through, the November lows at 1,191.5p - 1187.0p.
Following Persimmon’s results, investors will also be digesting Berkeley Group’s latest third quarter (Q3) 2025 sales and revenue release expected to be announced on the 14th of March. It should provide insight into conditions at the premium end of the housing market. Berkeley’s business is heavily concentrated in London and the South East, meaning its trading trends often reflect sentiment among higher-income buyers and international investors.
While Berkeley has historically been more resilient than many peers due to its focus on long-term developments and urban regeneration projects, the company has warned that elevated borrowing costs and slower transaction volumes continue to weigh on demand across parts of the capital.
Results published yesterday by Taylor Wimpey underline the challenging operating environment facing the industry. The housebuilder reported higher revenue of about £3.8 billion for 2025, up from £3.40 billion the previous year, reflecting increased completions and higher selling prices. However, profitability has come under pressure, with pre-tax profit falling sharply to £146.5m due mainly to exceptional costs linked to cladding remediation, while the housebuilder said the spring selling season had started well despite ongoing market uncertainty.
Sales activity has remained relatively steady, with reservation rates broadly unchangedYoY and cancellation levels stable. However, a lower order book heading into 2026 suggests that housebuilders are entering the new year with less visibility on future demand than in previous cycles.
The sector’s fragile investor sentiment was highlighted this week when Vistry shares plunged more than 25 percent on Wednesday after the company warned that margins could weaken in 2026 despite expectations for rising revenue and volumes.
The sharp sell-off was triggered by concerns about cost pressures, leadership changes and the company’s shift towards a partnerships model focused on affordable housing.
Analysts have also pointed to execution risks associated with that strategy, particularly in an environment where high interest rates continue to constrain housing affordability.
Taken together, the latest updates highlight the delicate balancing act facing UK housebuilders. On the one hand, there are signs of improving demand as mortgage rates stabilise and enquiries pick up. On the other hand, developers continue to face margin pressure from build costs, planning constraints and incentives used to support sales.
As Persimmon prepares to release its results and Berkeley provides further trading updates, investors will be looking for evidence that the sector is moving from stabilisation towards sustained growth. Until then, volatility like that seen in Vistry’s share price serves as a reminder that the UK housing market’s recovery remains uneven.
Investors interested in UK housebuilding sector exposure have several options. Here's how to approach investing:
Remember housebuilders are cyclical and sensitive to interest rates and economic conditions. Diversification reduces concentration risk whilst maintaining sector exposure.
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.